Aridis Pharmaceuticals, Inc. (ARDS)

OTCMKTS: ARDS · Delayed Price · USD
0.0740
-0.0032 (-4.15%)
Mar 1, 2024, 2:19 PM EST - Market closed

Aridis Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016
Net Income
-30.75-42.28-21.92-28.99-22.11-24.66-8.42
Depreciation & Amortization
0.490.440.340.340.280.060.02
Share-Based Compensation
1.482.252.132.011.661.610.86
Other Operating Activities
-0.3416.66-1.0218.48-4.115.431.45
Operating Cash Flow
-29.13-22.94-20.48-8.16-24.27-17.56-6.09
Capital Expenditures
-0.08-0.53-0.37-0.17-0.68-0.7-0.02
Acquisitions
0000-100
Change in Investments
-----1--
Other Investing Activities
----1--
Investing Cash Flow
-0.08-0.53-0.37-0.17-1.68-0.7-0.02
Dividends Paid
0-4.1300-1.3600
Common Stock Issued
12.6129.727.954.9625.0800
Other Financing Activities
2.179.130.730.041.3721.0625.51
Financing Cash Flow
14.7834.728.684.9925.0921.0625.51
Net Cash Flow
-14.4311.25-12.17-3.34-0.862.8119.4
Free Cash Flow
-29.21-23.47-20.84-8.33-24.95-18.26-6.11
Free Cash Flow Margin
---2084.30%-815.36%-904.90%-2122.67%-269.11%
Free Cash Flow Per Share
-1.56-1.91-2.27-0.99-7.93-2.31-0.77
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.